Merck & Co., Inc. (NYSE:MRK – Get Free Report) and PaxMedica (NASDAQ:PXMD – Get Free Report) are both healthcare companies, but which is the better stock? PaxMedica is trading at a lower price-to-earnings ratio than Merck & Co., Inc., indicating that it is currently the more affordable of the two stocks. Analyst RecommendationsThis is a breakdown of recent recommendations and price targets for Merck & Co., Inc. and PaxMedica, as reported by MarketBeat. Given Merck & Co., Inc.’s stronger consensus rating and higher possible upside, research analysts clearly believe Merck & Co., Inc. is more favorable than PaxMedica. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species.